Sir Peter Donnelly is Emeritus Professor of Statistical Science at the University of Oxford and was Director of the Wellcome Centre for Human Genetics from 2007-2017. Following a successful academic career in statistical and population genetics, Peter was centrally involved in the major advances in human genetics over the last 20 years, and in leadership of key projects, including the International HapMap Project, the genotyping of UK Biobank, and chairing the landmark Wellcome Trust Case Control Consortium. Peter co-founded and was then CEO of Genomics plc in 2014 with a vision of how to bring their research and knowledge of the genomic revolution to the benefit of healthcare systems and their patients. Their aim has been to use world-leading science to power new tools that make a difference in drug discovery and disease prevention. The company now employs more than 100 people in the UK and the US.